Your Messages Inbox
Your Article Summary
See Latest ArticlesApproval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 06/05/09
Chugai Pharmaceutical Co., Ltd. announced that the company has acquired the approval for the partial change of the API manufacturing method and the pharmaceutical formulation of a recombinant human erythropoietin from the Japanese Ministry of Health, Labour and Welfare on April.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Multaq Approved in the European Union for Patients with Atrial Fibrillation
Sanofi-aventis, 12/01/09
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09
FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS
BioMarin, 12/01/09
Article Search
Sponsor